Kallyope Raises $236M in Series D Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Column Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- A2 Biotherapeutics, Inc. ("A2 Bio") is a biotechnology company focused on the development of a first-in-class, logic-gated Tmod™ CAR T cell...
/PRNewswire/ -- A2 Biotherapeutics, Inc. ("A2 Bio") is a biotechnology company focused on the development of a first-in-class, logic-gated Tmod™ CAR T cell...
Theranos has become an instructive
Tech industry defenders blame the media for hyping up Theranos founder Elizabeth Holmes as the next Steve Jobs while critics see Holmes as an example of tech hubris run amok. Either way, Silicon Valley has been scarred.